Search

Author/Creator Li, Yu-Fa

1. A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival. (January 2023)

Authors:
Zhang, Chan-Yuan; Sun, Hao; Su, Jun-Wei; Chen, Yu-Qing; Zhang, Shi-Ling; Zheng, Ming-Ying; Li, Yu-Fa; Huang, Jie; Zhang, Chao; Tai, Zai-Xian; Cai, Miao; Zhang, Xu-Chao; Su, Jian; Xu, Chong-Rui; Yan, Hong-Hong; Chen, Hua-Jun; Wu, Yi-Long; Yang, Jin-Ji
Journal:
Lung cancer
Issue:
Volume 175(2023)
Page Start:
68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer. (November 2018)

Authors:
Liu, Si-yang; Dong, Zhong-yi; Wu, Si-pei; Xie, Zhi; Yan, Li-xu; Li, Yu-Fa; Yan, Hong-hong; Su, Jian; Yang, Jin-Ji; Zhou, Qing; Zhong, Wen-Zhao; Tu, Hai-Yan; Yang, Xue-Ning; Zhang, Xu-Chao; Wu, Yi-Long
Journal:
Lung cancer
Issue:
Volume 125(2018)
Page Start:
86
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer. (2nd November 2017)

Authors:
Dong, Zhong-Yi; Zhang, Jia-Tao; Liu, Si-Yang; Su, Jian; Zhang, Chao; Xie, Zhi; Zhou, Qing; Tu, Hai-Yan; Xu, Chong-Rui; Yan, Li-Xu; Li, Yu-Fa; Zhong, Wen-Zhao; Wu, Yi-Long
Journal:
Oncoimmunology
Issue:
Volume 6:Number 11(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search